Form 4: MACOM Technology Solutions CEO Sells Over 2,300 Shares Under Pre-Arranged Trading Plan
Insider Transaction Report
Stephen G. Daly, President and CEO of MACOM Technology Solutions Holdings, Inc., sold 2,380 shares of common stock on June 6, 2025, pursuant to a Rule 10b5-1 trading plan.
Summary
- Stephen G. Daly, who serves as Director, President, and CEO of MACOM Technology Solutions Holdings, Inc. (MTSI), reported the sale of common stock.
- On June 6, 2025, Mr. Daly disposed of a total of 2,380 shares of MTSI common stock through multiple transactions.
- The sales were executed at weighted average prices of $125.55 for 1,977 shares, $126.39 for 400 shares, and $128.76 for 3 shares.
- The shares were sold pursuant to a Rule 10b5-1 sales plan adopted by Mr. Daly on February 28, 2025.
- Following these transactions, Mr. Daly directly beneficially owns 24,573 shares of MACOM Technology Solutions Holdings, Inc. common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. While insider selling can sometimes be viewed negatively, the fact that these sales were conducted under a pre-arranged 10b5-1 plan mitigates concerns about opportunistic selling, indicating a planned financial management activity rather than a reaction to adverse company developments.
Positives
- The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, which indicates the transactions were scheduled in advance and not based on immediate, non-public information, enhancing transparency and reducing concerns about opportunistic insider trading.
Negatives
- Insider selling, even under a 10b5-1 plan, can sometimes be perceived negatively by investors as it may suggest that management believes the stock is fully valued or that there are limited upside opportunities in the near term.
Risks
- While the sale was pre-planned, significant insider selling can sometimes lead to negative market sentiment or speculation, potentially impacting the company's stock price.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Management Comments
- The shares were sold pursuant to a sales plan adopted by the Reporting Person on February 28, 2025, and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
Industry Context
This document reports an individual insider stock transaction and does not provide broader industry context or trends. MACOM Technology Solutions operates in the semiconductor industry, and such insider transactions are a routine part of executive compensation and personal financial management.
Comparison to Industry Standards
- Insider trading plans under Rule 10b5-1 are a standard practice among executives in publicly traded companies across all industries, including the semiconductor sector, to manage personal stock holdings while adhering to insider trading regulations.
- The disclosure of such transactions via Form 4 is a standard regulatory requirement for all U.S. public companies, including peers like Broadcom (AVGO), Analog Devices (ADI), and Qorvo (QRVO), ensuring transparency in executive stock movements.
Stakeholder Impact
- Shareholders: May observe the CEO's stock sales, which could lead to speculation about management's view on the company's valuation, though the 10b5-1 plan context helps to clarify the nature of the transaction.
Next Steps
- No specific future actions or milestones for the company are mentioned in this Form 4 filing, as it pertains solely to an individual's stock transactions.
Key Dates
| Date | Description |
|---|---|
| 02/28/2025 | Date the Rule 10b5-1 sales plan was adopted by Stephen G. Daly. |
| 06/06/2025 | Date of the reported stock transactions (sales). |
| 06/10/2025 | Date the Form 4 filing was signed by Ambra R. Roth, Attorney-in-Fact for Stephen G. Daly. |
Keywords
MACOM Technology Solutions Holdings, MTSI, Stephen G. Daly, Insider Sale, Form 4, 10b5-1 Plan, Stock Transaction, CEO, Director, Semiconductor
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.